AAAAAA

   
Results: 1-12 |
Results: 12
A single nucleotide polymorphism in the 5 ' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers
Authors: Wang, WW Spurdle, AB Kolachana, P Bove, B Modan, B Ebbers, SM Suthers, G Tucker, MA Kaufman, DJ Doody, MM Tarone, RE Daly, M Levavi, H Pierce, H Chetrit, A Yechezkel, GH Chenevix-Trench, G Offit, K Godwin, AK Struewing, JP
Citation: Ww. Wang et al., A single nucleotide polymorphism in the 5 ' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers, CANC EPID B, 10(9), 2001, pp. 955-960
Parity, oral contraceptives, and the risk of ovarian cancer among carriersand noncarriers of a BRCA1 or BRCA2 mutation
Authors: Modan, B Hartge, P Hirsh-Yechezkel, G Chetrit, A Lubin, F Beller, U Ben-Baruch, G Fishman, A Menczer, J Struewing, JP Tucker, MA Wacholder, S Ebbers, SM Friedman, E Piura, B
Citation: B. Modan et al., Parity, oral contraceptives, and the risk of ovarian cancer among carriersand noncarriers of a BRCA1 or BRCA2 mutation, N ENG J MED, 345(4), 2001, pp. 235-240
A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families
Authors: Goldstein, AM Liu, L Sherman, MG Hogg, D Tucker, MA Struewing, JP
Citation: Am. Goldstein et al., A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families, BR J CANC, 85(4), 2001, pp. 527-530
Genotype-phenotype relationships in US melanoma-prone families with CDKN2Aand CDK4 mutations
Authors: Goldstein, AM Struewing, JP Chidambaram, A Fraser, MC Tucker, MA
Citation: Am. Goldstein et al., Genotype-phenotype relationships in US melanoma-prone families with CDKN2Aand CDK4 mutations, J NAT CANC, 92(12), 2000, pp. 1006-1010
The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2
Authors: Lakhani, SR Gusterson, BA Jacquemier, J Sloane, JP Anderson, TJ van de Vijver, MJ Venter, D Freeman, A Antoniou, A McGuffog, L Smyth, E Steel, CM Haites, N Scott, RJ Goldgar, D Neuhausen, S Daly, PA Ormiston, W McManus, R Scherneck, S Ponder, BAJ Futreal, PA Peto, J Stoppa-Lyonnet, D Bignon, YJ Struewing, JP Bishop, DT Klijn, JGM Devilee, P Cornelisse, CJ Lasset, C Lenoir, G Barkardottir, RB Egilsson, V Hamann, U Chang-Claude, J Sobol, H Weber, B Easton, DF Stratton, MR
Citation: Sr. Lakhani et al., The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2, CLIN CANC R, 6(3), 2000, pp. 782-789
Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families
Authors: Biesecker, BB Ishibe, N Hadley, DW Giambarresi, TR Kase, RG Lerman, C Struewing, JP
Citation: Bb. Biesecker et al., Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families, AM J MED G, 93(4), 2000, pp. 257-263
Patients with double primary tumors in the breast and ovary - Clinical characteristics and BRCA1-2 mutations status
Authors: Fishman, A Dekel, E Chetrit, A Lerner-Geva, L Bar-Am, A Beck, D Beller, U Ben-Baruch, G Piura, B Friedman, E Struewing, JP Modan, B
Citation: A. Fishman et al., Patients with double primary tumors in the breast and ovary - Clinical characteristics and BRCA1-2 mutations status, GYNECOL ONC, 79(1), 2000, pp. 74-78
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-pronefamilies
Authors: Ciotti, P Struewing, JP Mantelli, M Chompret, A Avril, MF Santi, PL Tucker, MA Bianchi-Scarra, G Bressac-de Paillerets, B Goldstein, AM
Citation: P. Ciotti et al., A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-pronefamilies, AM J HU GEN, 67(2), 2000, pp. 311-319
Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers
Authors: Lee, JS Wacholder, S Struewing, JP McAdams, M Pee, D Brody, LC Tucker, MA Hartge, P
Citation: Js. Lee et al., Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers, J NAT CANC, 91(3), 1999, pp. 259-263
Histopathologic features of ovaries at increased risk for carcinoma - A case-control analysis
Authors: Sherman, ME Lee, JS Burks, RT Struewing, JP Kurman, RJ Hartge, P
Citation: Me. Sherman et al., Histopathologic features of ovaries at increased risk for carcinoma - A case-control analysis, INT J GYN P, 18(2), 1999, pp. 151-157
Founder BRCA1/2 mutations among male patients with breast cancer in Israel
Authors: Struewing, JP Coriaty, ZM Ron, E Livoff, A Konichezky, M Cohen, P Resnick, MB Lifzchiz-Mercerl, B Lew, S Iscovich, J
Citation: Jp. Struewing et al., Founder BRCA1/2 mutations among male patients with breast cancer in Israel, AM J HU GEN, 65(6), 1999, pp. 1800-1802
The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews
Authors: Hartge, P Struewing, JP Wacholder, S Brody, LC Tucker, MA
Citation: P. Hartge et al., The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews, AM J HU GEN, 64(4), 1999, pp. 963-970
Risultati: 1-12 |